These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16601476)

  • 21. Ultrasonographic and biochemical markers in prenatal detection of Down's syndrome and neural tube defects.
    Calda P
    Funct Dev Morphol; 1992; 2(2):135-7. PubMed ID: 1450459
    [No Abstract]   [Full Text] [Related]  

  • 22. [Down syndrome screening in France: the worst consensus].
    Rozenberg P; Bussières L; Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):95-103. PubMed ID: 17289296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of first-trimester tricuspid regurgitation for Down syndrome screening.
    McGee DC
    J Perinat Neonatal Nurs; 2008; 22(4):282-90; quiz 292-3. PubMed ID: 19011492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Womens' preference in Down syndrome screening.
    de Graaf IM; Tijmstra T; Bleker OP; van Lith JM
    Prenat Diagn; 2002 Jul; 22(7):624-9. PubMed ID: 12124700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
    Sonek J; Cicero S; Nicolaides K
    Am J Obstet Gynecol; 2007 Jan; 196(1):e19. PubMed ID: 16996461
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system.
    Kublickas M; Crossley J; Aitken D
    Acta Obstet Gynecol Scand; 2009; 88(6):635-8, 7p following 638. PubMed ID: 19330568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
    Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contingent screening for Down syndrome completed in the first trimester: a multicenter study.
    Muñoz-Cortes M; Arigita M; Falguera G; Seres A; Guix D; Baldrich E; Acera A; Torrent A; Rodriguez-Veret A; Lopez-Quesada E; Garcia-Moreno R; Gonce A; Borobio V; Borrell A
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):396-400. PubMed ID: 21674658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?
    Roman AS; Gupta S; Fox NS; Saltzman D; Klauser CK; Rebarber A
    Fetal Diagn Ther; 2015; 37(3):206-10. PubMed ID: 25034077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enlarged nuchal translucency with normal karyotype].
    Oueslati A; Amroussi A; Youssef A; Ben Ghezala M; Agrebi W; Ben Mefteh M; Oueslati H
    Tunis Med; 2008 Jun; 86(6):617-8. PubMed ID: 19216466
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].
    Charasson T; Ko-Kivok-Yun P; Martin F; Sarramon MF
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(7):671-8. PubMed ID: 9471429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening in the presence of a vanished twin: nuchal translucency or combined screening test?
    Sankaran S; Rozette C; Dean J; Kyle P; Spencer K
    Prenat Diagn; 2011 Jun; 31(6):600-1. PubMed ID: 21413040
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nuchal translucency: this is not so simple!].
    Constant M
    Gynecol Obstet Fertil; 2014 Dec; 42(12):820-1. PubMed ID: 25456489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.